All lobbying filings

SPLITOAK STRATEGIES LLC

Lobbying for JOHNSON & JOHNSON SERVICES, INC. · Global biopharmaceutical, medical device and consumer product manufacturer.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 3

HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025

Lobbying activity 1

Medicare/Medicaid

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025/Public Law No: 119-44 Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.